2017 annual financial data
Ernexa Therapeutics 2017 Operating cash flow margin
Ernexa Therapeutics 2017 operating cash flow margin with verified reported valu…
Direct answer
Operating cash flow margin was 2.58%.
Operating income was -1,402,000 USD and net income was -1,077,000 USD.
Operating cash flow was 549,000 USD.
Get free Ernexa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 21,274,000 USD
- Operating income
- -1,402,000 USD
- Net income
- -1,077,000 USD
- Operating cash flow
- 549,000 USD